March 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, KLA Corp and Oxford Industries, on Friday.
HIGHLIGHTS
* Applied Materials Inc AMAT.O: Jefferies raises to buy from hold |
* KLA Corp KLAC.O: Jefferies cuts to hold from buy |
* Lineage Inc LINE.O: Citigroup initiates coverage with neutral rating |
* NRG Energy Inc NRG.N: Citigroup raises target price to $133 from $100 |
* Oxford Industries Inc OXM.N: KeyBanc cuts to sector weight from overweight |
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.
* Acuity Brands, Inc. AYI.N: Wells Fargo cuts target price to $290 from $336 |
* Acumen Pharmaceuticals Inc ABOS.O: UBS cuts target price to $4 from $6 |
* Applied Materials Inc AMAT.O: Jefferies raises target price to $195 from $185 |
* Applied Materials Inc AMAT.O: Jefferies raises to buy from hold |
* Beam Therapeutics Inc BEAM.O: BofA Global Research raises to buy from neutral |
* Bioatla Inc BCAB.O: BTIG cuts target price to $10 from $13 |
* Blue Owl Capital Inc OWL.N: CFRA initiates coverage with buy rating; PT $27 |
* Braze Inc BRZE.O: Raymond James raises target price to $48 from $45 |
* Braze Inc BRZE.O: Raymond James raises target price to $48 from $45 |
* Braze Inc BRZE.O: Wells Fargo raises target price to $55 from $50 |
* Camden Property Trust CPT.N: Citigroup raises target price to $138.00 from $125.00 |
* Camden Property Trust CPT.N: Citigroup raises to buy from neutral |
* Castle Biosciences Inc CSTL.O: Guggenheim cuts target price to $30 from $37 |
* Centerpoint Energy CNP.N: Citigroup raises target price to $37 from $30 |
* CH Robinson Worldwide Inc CHRW.O: BofA Global Research cuts PO to $119 from $122 |
* Clearside Biomedical Inc CLSD.O: Needham cuts target price to $4 from $6 |
* Comerica Incorporated CMA.N: Wells Fargo cuts target price to $67 from $70 |
* Cryoport Inc CYRX.O: Guggenheim cuts target price to $10 from $11 |
* $Danaher Corp(DHR-W)$ DHR.N: Guggenheim cuts target price to $250 from $275 |
* Digital Realty Trust Inc DLR.N: Mizuho cuts target price to $177 from $211 |
* Elevance Health ELV.N: Bernstein raises target price to $585 from $511 |
* EOG Resources Inc EOG.N: Raymond James cuts target price to $154 from $175 |
* Equillium Inc EQ.O: Leerink Partners cuts target price to $1 from $3 |
* Equillium Inc EQ.O: Leerink Partners cuts to market perform from outperform |
* Equinix Inc EQIX.O: Mizuho cuts target price to $1,053 from $1,094 |
* Exact Sciences Corp EXAS.O: Guggenheim cuts target price to $60 from $73 |
* Federal Realty Investment Trust FRT.N: Citigroup cuts PT to $106.00 from $135.00 |
* Federal Realty Investment Trust FRT.N: Citigroup cuts to neutral from buy |
* Fifth Third Bancorp FITB.O: Wells Fargo cuts target price to $50 from $54 |
* First Solar Inc FSLR.O: Jefferies raises target price to $202 from $201 |
* GE Aerospace GE.N: Bernstein raises target price to $250 from $232 |
* GE Vernova Inc GEV.N: Truist Securities cuts target price to $440 from $470 |
* Getty Realty Corp GTY.N: UBS initiates coverage with neutral rating; PT $32 |
* H.B. Fuller Company FUL.N: Baird cuts target price to $60 from $73 |
* H.B. Fuller Company FUL.N: JP Morgan cuts target price to $50 from $60 |
* Hexcel Corp HXL.N: Truist Securities cuts target price to $80 from $85 |
* Hudson Pacific Properties Inc HPP.N: BMO raises target price to $5 from $4 |
* Hudson Pacific Properties Inc HPP.N: BMO raises to outperform from market perform |
* Huntsman Corporation HUN.N: Wells Fargo cuts target price to $20 from $22 |
* Illumina Inc ILMN.O: Guggenheim cuts target price to $122 from $150 |
* Jefferies Financial Group JEF.N: Morgan Stanley cuts target price to $75.00 from $81.00 |
* Keycorp KEY.N: Wells Fargo cuts target price to $20 from $22 |
* Kimberly-Clark Corporation KMB.N: Wells Fargo raises target price to $140 from $130 |
* KLA Corp KLAC.O: Jefferies cuts to hold from buy; cuts PT to $725 from $875 |
* Lam Research LRCX.O: Jefferies raises target price to $100 from $95 |
* Lineage Inc LINE.O: Citigroup initiates coverage with neutral rating; PT $64 |
* M&T Bank Corporation MTB.N: Wells Fargo cuts target price to $185 from $205 |
* Merit Medical Systems MMSI.O: JP Morgan initiates coverage with overweight rating; PT $120 |
* Mondelez MDLZ.O: Citigroup raises target price to $75 from $63 |
* Ncino Inc NCNO.O: KBW cuts target price to $40 from $44 |
* Northern Trust Corporation NTRS.O: Wells Fargo cuts target price to $118 from $119 |
* NRG Energy Inc NRG.N: Citigroup raises target price to $133 from $100 |
* Onto Innovation Inc ONTO.N: Jefferies cuts target price to $175 from $245 |
* Onto Innovation Inc ONTO.N: Stifel cuts target price to $200 from $250 |
* Oxford Industries Inc OXM.N: KeyBanc cuts to sector weight from overweight |
* Oxford Industries Inc OXM.N: UBS cuts target price to $57 from $66 |
* Plus Therapeutics, Inc PSTV.O: H.C. Wainwright cuts target price to $5.5 from $8 |
* PNC Financial Services Group, Inc. PNC.N: Wells Fargo cuts PT to $230 from $235 |
* PVH Corp PVH.N: TD Cowen cuts target price to $110 from $134 |
* Regions Financial Corporation RF.N: Wells Fargo cuts target price to $26 from $28 |
* Regulus Therapeutics Inc RGLS.O: Wells Fargo raises target price to $6 from $3 |
* Regulus Therapeutics Inc RGLS.O: Wells Fargo raises to overweight from equal weight |
* Robinhood Markets Inc HOOD.O: Needham cuts target price to $62 from $70 |
* Schneider National Inc SNDR.N: BofA Global Research cuts PO to $25 from $34 |
* Schneider National Inc SNDR.N: BofA Global Research cuts to neutral from buy |
* Sensei Biotherapeutics Inc SNSE.O: Oppenheimer raises target price to $4 from $3.5 |
* Septerna Inc SEPN.O: JP Morgan cuts target price to $27 from $38 |
* Septerna Inc SEPN.O: Wells Fargo cuts target price to $11 from $14 |
* Soleno Therapeutics Inc SLNO.O: Stifel raises target price to $108 from $74 |
* Southwest Airlines Co LUV.N: Citigroup raises target price to $30 from $27 |
* State Street Corporation STT.N: Wells Fargo cuts target price to $113 from $118 |
* Sunoco LP SUN.N: Barclays cuts target price to $61.00 from $62.00 |
* TD Synnex SNX.N: Barclays cuts target price to $125.00 from $148.00 |
* TD Synnex SNX.N: JP Morgan cuts target price to $125 from $150 |
* TD Synnex SNX.N: Raymond James cuts target price to $125 from $150 |
* TD Synnex SNX.N: UBS cuts target price to $138 from $150 |
* Tempest Therapeutics Inc TPST.O: Scotiabank cuts target price to $7 from $13 |
* Tempest Therapeutics Inc. TPST.O: H.C. Wainwright cuts target price to $16 from $47 |
* the Goldman Sachs Group, Inc. GS.N: Wells Fargo cuts target price to $680 from $720 |
* Third Harmonic Bio Inc THRD.O: Stifel cuts to hold from buy; cuts PT to $5 from $23 |
* Truist Financial Corporation TFC.N: Wells Fargo cuts target price to $50 from $52 |
* Twist Bioscience Corp TWST.O: Guggenheim cuts target price to $50 from $58 |
* U.S. Bancorp USB.N: Wells Fargo cuts target price to $56 from $62 |
* Verint Systems Inc VRNT.O: Wedbush cuts target price to $30 from $38 |
* Voya Financial Inc VOYA.N: BofA Global Research cuts PO to $71.00 from $79.00 |
* Voya Financial Inc VOYA.N: BofA Global Research cuts to underperform from neutral |
* Westlake Corp WLK.N: Truist Securities cuts target price to $155 from $166 |
* Winnebago Industries Inc WGO.N: BMO cuts target price to $60 from $70 |
* Winnebago Industries Inc WGO.N: Truist Securities cuts target price to $50 from $58 |
* Worksport Ltd. WKSP.O: H.C. Wainwright raises target price to $11.5 from $1.5 |
* XPO Inc XPO.N: BofA Global Research cuts price objective to $131 from $150 |
* Zions Bancorporation ZION.O: Wells Fargo cuts target price to $58 from $62 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.